Quantitative analysis of 3alpha,6alpha,24-trihydroxy-24,24-di(trifluoromethyl)-5beta-cholane, a potent synthetic steroidal liver X receptor agonist in plasma using liquid chromatography-tandem mass spectrometry.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Jian GuoRichard B van Breemen

Abstract

The steroidal liver X receptor agonist, 3alpha,6alpha,24-trihydroxy-24,24-di(trifluoromethyl)-5beta-cholane (ATI-829) is a potential therapeutic agent for the treatment of atherosclerosis. A sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for the quantification of ATI-829 in mouse plasma was developed and validated. Proteins in a 25 microL aliquot of mouse plasma were precipitated, and ATI-829 was extracted from the precipitate by the addition of 125 microL methanol. The overall extraction efficiency was greater than 99%. LC-MS-MS with negative ion electrospray and selected reaction monitoring was used for the quantitative analysis of ATI-829. The lower limit of quantitation of ATI-829 corresponded to 5.0 ng/mL (9.7 nM) plasma. Interference from matrix was negligible. The calibration curve was linear over the range 5-2000 ng/mL. The intra-day precision and inter-day precision of the analyses were <4.5% and <6%, respectively, and the accuracy ranged from 92% to 103%. ATI-829 in plasma was stable for at least 6 h at room temperature, 1 week at 4 degrees C, and 3 weeks at -20 degrees C. The validated method was then utilized for pharmacokinetic studies of ATI-829 administered to mice.

References

Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·C SongS Liao
Oct 31, 1998·Current Opinion in Genetics & Development·D J PeetD J Mangelsdorf
Oct 29, 2000·The American Journal of Cardiology·P Cullen
Nov 23, 2000·Genes & Development·J R SchultzB Shan
Nov 29, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·B K Matuszewski
Mar 25, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Nan WangAlan R Tall
Feb 17, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Patricia G YanceySergio Fazio
Feb 26, 2008·Journal of Pharmaceutical and Biomedical Analysis·Cliff Y ChenZheng Yang
Sep 20, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yazen AlnoutiCurtis D Klaassen
Oct 13, 2009·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Max SchererGerhard Liebisch
Dec 17, 2009·Journal of Lipid Research·William J Griffiths, Jan Sjövall

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.